AgomAb Therapeutics NV (AGMB) Short-term Investments (2024 - 2026)
Agomab Therapeutics (AGMB) recorded Short-term Investments of $15,111 in Q2 2026.
Powered by 
Analysis
AgomAb Therapeutics NV (AGMB) Short-term Investments (2024 - 2026) Analysis & Trends
At the end of FY2025, Agomab Therapeutics reported Short-term Investments of $12,428, down 4.3% from FY2024.
- Across earlier years, Short-term Investments came in at $12,988 in FY2024.
Peer Set
Peer Comparison
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 14,848.66 |
| Dec 31, 2025 | 12,922.02 |
| Dec 31, 2024 | 12,487.38 |
API Access
AgomAb Therapeutics NV Short-term Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=short-term-investments&ticker=AGMB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "short-term-investments", "ticker": "AGMB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=short-term-investments&ticker=AGMB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();